Clinicians who enter patients into randomised controlled trials should be acknowledged

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7060.821b (Published 28 September 1996) Cite this as: BMJ 1996;313:821
  1. Su Mason, Research manager,
  2. Shona Haining, Research manager
  1. Yorkshire Clinical Trials and Research Unit, Leeds LS16 6QB

    EDITOR,—It is generally accepted that multicentre randomised controlled trials are important for the adequate assessment of health technologies1 and benefit individual patients.2 3 4 They need to be large enough to allow sufficient statistical power to answer the research questions posed. It is also known that only a small proportion of eligible patients are …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription